{"database": "lobbying", "table": "lobbying_activities", "rows": [[3147102, "b56ca7fd-a7cb-4f5f-9ef9-e1bb3d55560c", "Q1", "60 PLUS ASSOCIATION", 41988, "60 PLUS ASSOCIATION", 2024, "first_quarter", "CSP", "Signed a comment letter regarding a Joint USPTO-FDA Collaboration Initiatives (Docket No. PTO-P-2022-0037) which will USPTO-FDA Collaboration Initiatives The USPTO's initiatives aim to enhance collaboration with other agencies; ensure that the USPTO issues robust and reliable patents; improve the process for post-grant challenges of issued patents; and improve public participation in the patent system.", "Food & Drug Administration (FDA),Patent & Trademark Office (PTO)", 0, 0, "2024-04-16T15:48:29-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3147102"], "units": {}, "query_ms": 0.3769689938053489, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}